Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
2.4
2.4
Journals
JCDD
Special Issues
New Developments and Challenges in Transcatheter Treatments of Structural Heart...
share announcement

New Developments and Challenges in Transcatheter Treatments of Structural Heart Diseases

A special issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425). This special issue belongs to the section "Cardiac Surgery".

Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 4472

Special Issue Editors

Dr. Andrea Buono

E-Mail Website
Guest Editor
Interventional Cardiology Unit, Fondazione Poliambulanza, 25124 Brescia, Italy
Interests: coronary syndrome
Dr. Elisabetta Moscarella

E-Mail Website
Guest Editor
Department of Translational Medical Sciences, University of Campania Luigi Vanvitelli, Caserta, Italy
Interests: PCI; myocardial infarction; coronary artery disease; interventional cardiology; coronary angiography; acute myocardial infarction; cardiac catheterization; coronary angioplasty angioplasty

Special Issue Information

Dear Colleagues,

Structural heart disease (SHD) refers to conditions that affect the heart’s valves, walls, chambers or muscles, and is commonly found in daily practice. To offer the best therapeutic solution for patients, various heart specialists are often involved. Over the past few years, a great deal of effort was made to develop  the transcatheter treatments of SHD. The continuous increase in operators’ skills, in association with further engineering refinements, makes transcatheter treatments a contemporary gold-standard therapy for SHD. Advantages of less invasive therapies are unequivocally clear and allow us to expand treatment indications to a broader and increasingly more complex population of patients. Similarly, it is important to keep in mind that several challenges still exist in this field, and new attempts to minimize the risk of complication are an ongoing priority. New devices and techniques to treat valves, septal defects and other issues associated with SHD have emerged on the market to improve the efficacy and safety of SHD procedures. For this reason, this Special Issue will present innovations and emerging findings concerning transcatheter treatments of SHD.

Dr. Andrea Buono
Dr. Elisabetta Moscarella
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • structural heart disease
  • TAVI
  • mitral transcatheter therapies
  • tricuspid transcatheter therapies
  • septal defect
  • heart failure treatments

Published Papers (3 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Review

12 pages, 792 KiB  
Review
Transcatheter Aortic Valve Therapy for Bicuspid Aortic Valve Stenosis
by Nalin H. Dayawansa, Samer Noaman, Lung En Teng and Nay Min Htun
J. Cardiovasc. Dev. Dis. 2023, 10(10), 421; https://doi.org/10.3390/jcdd10100421 - 9 Oct 2023
Viewed by 1832
Abstract
Transcatheter aortic valve implantation (TAVI) has become first-line treatment for older adults with severe aortic stenosis (AS), however, patients with bicuspid aortic valve (BAV) have been traditionally excluded from randomised trials and guidelines. As familiarity and proficiency of TAVI operators have improved, case-series [...] Read more.
Transcatheter aortic valve implantation (TAVI) has become first-line treatment for older adults with severe aortic stenosis (AS), however, patients with bicuspid aortic valve (BAV) have been traditionally excluded from randomised trials and guidelines. As familiarity and proficiency of TAVI operators have improved, case-series and observational data have demonstrated the feasibility of successful TAVI in bicuspid aortic valve aortic stenosis (BAV-AS), however, patients with BAV-AS have several distinct characteristics that influence the likelihood of TAVI success. This review aims to summarise the pathophysiology and classification of BAV, published safety data, anatomical challenges and procedural considerations essential for pre-procedural planning, patient selection and procedural success of TAVI in BAV. Full article
(This article belongs to the Special Issue New Developments and Challenges in Transcatheter Treatments of Structural Heart Diseases)
►▼ Show Figures

Figure 1

31 pages, 28195 KiB  
Review
Balloon Dilatation in the Management of Congenital Obstructive Lesions of the Heart: Review of Author’s Experiences and Observations—Part II
by P. Syamasundar Rao
J. Cardiovasc. Dev. Dis. 2023, 10(7), 288; https://doi.org/10.3390/jcdd10070288 - 6 Jul 2023
Viewed by 986
Abstract
While investigating the outcomes of balloon dilatation procedures in patients with congenital obstructive lesions of the heart, several parallel observations were made. The purpose of this review is to present these observations/phenomena/innovations related to balloon dilatation of pulmonary stenosis (PS), aortic stenosis (AS), [...] Read more.
While investigating the outcomes of balloon dilatation procedures in patients with congenital obstructive lesions of the heart, several parallel observations were made. The purpose of this review is to present these observations/phenomena/innovations related to balloon dilatation of pulmonary stenosis (PS), aortic stenosis (AS), and aortic coarctation (AC). In subjects who had balloon pulmonary valvuloplasty (BPV), development of infundibular obstruction, electrocardiographic (ECG) changes, changes in right ventricular filling, role of balloon/annulus ratios on the results of BPV, and double balloon vs. single balloon BPV will be reviewed. In patients who had balloon aortic valvuloplasty (BAV), causes of aortic insufficiency and trans-umbilical venous approach for BAV are tackled. In children who had balloon angioplasty (BA) of AC, aortic remodeling and biophysical response after BA of AC are discussed. Full article
(This article belongs to the Special Issue New Developments and Challenges in Transcatheter Treatments of Structural Heart Diseases)
►▼ Show Figures

Figure 1

51 pages, 54843 KiB  
Review
Balloon Dilatation in the Management of Congenital Obstructive Lesions of the Heart: Review of Author’s Experiences and Observations—Part I
by P. Syamasundar Rao
J. Cardiovasc. Dev. Dis. 2023, 10(6), 227; https://doi.org/10.3390/jcdd10060227 - 23 May 2023
Cited by 1 | Viewed by 1219
Abstract
Balloon dilatation techniques became available to treat congenital obstructive lesions of the heart in the early/mid-1980s. The purpose of this review is to present the author’s experiences and observations on the techniques and outcomes of balloon dilatation of pulmonary stenosis (PS), aortic stenosis [...] Read more.
Balloon dilatation techniques became available to treat congenital obstructive lesions of the heart in the early/mid-1980s. The purpose of this review is to present the author’s experiences and observations on the techniques and outcomes of balloon dilatation of pulmonary stenosis (PS), aortic stenosis (AS) and aortic coarctation (AC), both native and postsurgical re-coarctations. Balloon dilatation resulted in a reduction of peak pressure gradient across the obstructive lesion at the time of the procedure as well as at short-term and long-term follow-ups. Complications such as recurrence of stenosis, valvar insufficiency (for PS and AS cases) and aneurysm formation (for AC cases) have been reported, but infrequently. It was recommended that strategies be developed to prevent the reported complications. Full article
(This article belongs to the Special Issue New Developments and Challenges in Transcatheter Treatments of Structural Heart Diseases)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-3
Back to TopTop